The genetic alterations of TP53 and CASP8 from HNSCC TCGA datasets were displayed by Oncoprint, which showed 71% TP53 and 13% CASP8 mutation rates, mainly in HPV(−) HNSCC (Supplemental Figure 2A). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.